Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 study.

Autor: Yang, Jianliang1 (AUTHOR), Song, Yongping2 (AUTHOR), Zhou, Keshu2 (AUTHOR), Li, Zhiming3 (AUTHOR), Zhang, Mingzhi4 (AUTHOR), Jing, Hongmei5 (AUTHOR), Wang, Zhen6 (AUTHOR), Yu, Li7 (AUTHOR), Meng, Wei8 (AUTHOR), Lu, Qiying8 (AUTHOR), Tian, Wenzhi8 (AUTHOR), Shi, Yuankai1 (AUTHOR) syuankai@cicams.ac.cn
Zdroj: Journal of Hematology & Oncology. 12/18/2024, Vol. 17 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje